| Net income including noncontrolling interest | 124.4M |
| Depreciation and amortization | 58.4M |
| Provision for bad debt | 5.4M |
| Gain on short-term investments | |
| Deferred income tax provision (benefit) | -14.5M |
| Share-based payment award compensation costs | 14.5M |
| Foreign currency (gains) losses, net | -18.3M |
| Other | 2.6M |
| Accounts receivable, net | -212.3M |
| Inventories | -89.3M |
| Prepaid expenses | -200K |
| Transaction taxes receivable | |
| Other current assets | -30.4M |
| Short-term derivative assets, net | |
| Non-current other assets | 13.6M |
| Accounts payable | 213.2M |
| Customer deposits | -10.5M |
| Transaction taxes payable | |
| Short-term derivative liabilities, net | |
| Accrued expenses and other current liabilities | -144.5M |
| Non-current income tax and other long-term liabilities | -4M |
| Total adjustments | 95.9M |
| Net cash (used in) provided by operating activities | |
| Capital expenditures | -28.9M |
| Issuance of short term note receivable | |
| Repayment of short term note receivable | |
| Acquisition of businesses, net of cash acquired | |
| Net cash used in investing activities | |
| Dividends paid on common stock | -12.5M |
| Payment of assumed employee benefits | |
| Borrowings under revolving credit facility | |
| Repayments under revolving credit facility | |
| Capital contribution for joint venture | |
| Repayments of debt other than senior revolving credit facility | |
| Proceeds from exercise of stock options | |
| Federal and state tax benefits resulting from tax deductions in excess of the compensation cost recognized for share-based payment awards | 1.6M |
| Purchases of stock tendered by employees to satisfy the required withholding taxes related to share-based payment awards | -4.2M |
| Net cash provided by (used in) financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | |
| Net decrease in cash and cash equivalents | 289.9M |
| Cash and cash equivalents, at beginning of period | 582.5M |
| Cash and cash equivalents, at end of period | 872.3M |